FindTrial
Sign In

Aniseikonia in Epiretinal Membrane Patients

Aniseikonia in Epiretinal Membranes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03661593
Enrollment
25
Registered
2018-09-07
Start date
2017-11-01
Completion date
2019-11-30
Last updated
2018-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epiretinal Membrane

Brief summary

Examination of aniseikonia in epiretinal membranes patients before and after surgery

Detailed description

Phakic patients woth epiretinal membranes are examined for aniseikonia and refractive status before and after surgery. Follow up is one year.

Interventions

OTHERCataract guideline

The patients gets an IOL according to cataract guideline correcting the ametropia

Sponsors

Glostrup University Hospital, Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Masking done by a third person following computer randomization

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Epiretinal membrane Phakic on both eyes

Exclusion criteria

* no previous eye surgeries * refractive status +/- 2 seq

Design outcomes

Primary

MeasureTime frameDescription
Aniseikonia1 yearMeasure amount of aniseikonia by measuring aniseikonia with both computer program aniseikonia inspector and the New Aniseikonia test

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026